Alkermes

ISIN IE00B56GVS15

 | 

WKN A1JKVH

Market cap (in EUR)
4,019 m
Country
Ireland
Sector
Healthcare
Dividend yield
0.00%
 

Overview

Description

Alkermes Plc is a global biopharmaceutical company, which engages in the business of developing, manufacturing, and commercializing medicines designed to address unmet medical needs of patients in major therapeutic areas such as alcohol dependence, opioid dependence, schizophrenia and bipolar I disorder, and a pipeline of product candidates in development for neurological disorders and cancer. Its proprietary products include ARISTADA, ARISTADA INITIO, LYBALVI, and VIVITROL. The company was founded in 1987 and is headquartered in Dublin, Ireland.
Show more Show less
Healthcare Biopharmaceuticals System-Specific Biopharmaceuticals Ireland

Financials

Key metrics

Market capitalisation, EUR 4,019 m
EPS, EUR 1.83
P/B ratio 2.7
P/E ratio 14.2
Dividend yield 0.00%

Income statement (2024)

Revenue, EUR 1,440 m
Net income, EUR 344 m
Profit margin 23.89%

What ETF is Alkermes in?

There are 5 ETFs which contain Alkermes. All of these ETFs are listed in the table below. The ETF with the largest weighting of Alkermes is the iShares Nasdaq US Biotechnology UCITS ETF USD (Dist).
ETF Weight Investment focus Fund size (in m EUR)
iShares Nasdaq US Biotechnology UCITS ETF USD (Dist) 0.44%
Equity
United States
Health Care
Biotech
45
iShares S&P SmallCap 600 UCITS ETF 0.35%
Equity
United States
Small Cap
1,735
Vanguard ESG Global All Cap UCITS ETF (USD) Distributing 0.01%
Equity
World
Social/Environmental
485
Vanguard ESG North America All Cap UCITS ETF (USD) Distributing 0.01%
Equity
North America
Social/Environmental
27
JPMorgan BetaBuilders US Small Cap Equity UCITS ETF USD (dist) 0.08%
Equity
United States
Small Cap
179
— Data provided by Trackinsight, etfinfo, Xignite Inc., gettex, FactSet and justETF GmbH.

Quotes are either real-time (gettex) or 15 minutes delayed stock exchange quotes or NAVs (daily published by the fund provider). By default, ETF returns include dividend payments (if applicable). There is no warranty for completeness, accuracy and correctness for the displayed information.